Patch testing for evaluating drug reactions due to systemic antibiotics.
Several studies have evaluated patch testing for the diagnosis of drug eruptions, but widespread acceptance of this procedure is lacking in North America. The objective of this review is to address patch testing for the evaluation of exanthematous drug eruptions due to systemic antibiotics, using a MEDLINE database search for articles in English on patch testing for systemic drug eruptions caused by antibiotics.
Cham
Peter M H
PM
University of Minnesota, School of Medicine, Minneapolis, MN, USA.
Warshaw
Erin M
EM
D000485:Allergens / Q000009:adverse effects* / Q000276:immunology; D000900:Anti-Bacterial Agents / Q000009:adverse effects*; D002981:Clindamycin / Q000009:adverse effects; D003429:Cross Reactions; D003875:Drug Eruptions / Q000175:diagnosis* / Q000209:etiology / Q000503:physiopathology; D006801:Humans; D010328:Patch Tests / Q000009:adverse effects / Q000379:methods*; D025762:Pristinamycin / Q000009:adverse effects; D015203:Reproducibility of Results; D012882:Skin Tests; D047090:beta-Lactams / Q000009:adverse effects
D000485:Allergens; D000900:Anti-Bacterial Agents; D025762:Pristinamycin; D047090:beta-Lactams; D002981:Clindamycin